In our study, we demonstrated that in OC, EZH2 transcriptionally upregulated IDH2 to potentiate metabolic rewiring by enhancing tricarboxylic acid cycle (TCA cycle) activity, which provide a novel mechanism by EZH2 to promote tumor growth. The gene discussed is EZH2; the disease is neoplasm.